Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Neoadjuvant Therapy × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Medulloblastoma 1 Liposarcoma 1 Leiomyosarcoma 1 Intermittent Fasting 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Gemcitabine 2 Biopsy 2 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 liposomal doxorubicin 1 futibatinib 1 cabozantinib 1 anlotinib 1 abemaciclib 1 Tissue Banks 1 Temozolomide 1 Tablets 1 Surgical Procedures, Operative 1 Standard of Care 1 Rosuvastatin Calcium 1 Quality of Life 1 PM 01183 1 Neoadjuvant Therapy 1 Midazolam 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Erlotinib Hydrochloride 1 Docetaxel 1 Digoxin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04031677 2026-03-18

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡